Premier Perspectives The blog for insider insights in clinical development Medical and Regulatory Affairs The FDA Is Ending Its Rare Pediatric Disease Priority Review Vouchers – and Time Is Running Out to Get One By Irene Figari July 31, 2020 × ALSO OF INTEREST7 Questions About Clinical Evaluations for MDRDesigning Pediatric Analgesic Treatment...Nostalgia or Shell Shock? Assessing PTSD Is a...
